Subscribe to Newsletter


Reset Filter
You have a filtered search result

81 search results for ‘*’

Discovery & Development Drug Delivery

The Cutting Room Floor

| Jamie Irvine | 2 min read

Scientists are targeting EV-A71 RNA viruses using an adeno-associated virus-delivered CRISPR-Cas13 editor

Manufacture Facilities

Center of Excellence Opens for RNA

| Stephanie Vine | 4 min read

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Discovery & Development Drug Discovery

Meet an AI Model that Predicts Teratogenicity

| Jamie Irvine | 3 min read

Researchers demonstrate that complex data analysis paired with artificial intelligence can predict additional causes of Teratogenicity

Business & Regulation Trends & Forecasts

The Battle Outside Raging

| Rob Coker | 2 min read

Climate change is real – it’s happening now – and it will take an awesome effort from the pharma industry to mitigate it

Manufacture Technology and Equipment

Nominate the Best Drug Development and Manufacturing Technologies

| Stephanie Vine

Nominations are open now – but only until October 10.

Discovery & Development Drug Discovery

Exploring Alzheimer’s in Women

| Jamie Irvine | 2 min read

Studying the link between Alzheimer’s risk, estrogen levels, and menopausal status in women

Discovery & Development Drug Discovery

FDA Approves First OTC Contraceptive

| Jamie Irvine | 2 min read

Perrigo’s Opill receives FDA approval following unanimous support from advisory committees

Discovery & Development Drug Delivery

The Realities of Herbal Remedies

| Jamie Irvine | 3 min read

How scientists extracted a treatment for episodic ataxia from traditional Kwakwaka'wakw medicine

Discovery & Development Drug Discovery

Honey, I Shrunk the Molecules

| Jamie Irvine | 2 min read

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Discovery & Development Drug Discovery

Expanding Targets for ADCs

| Marwan Alsarraj | 2 min read

Adcendo signs antibody drug conjugate licensing deal with DualityBio.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine